• 1
    American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society, 2003: 152.
  • 2
    Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004; 54: 829.
  • 3
    Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004; 101: 327.
  • 4
    Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer. 2000; 88: 23982424.
  • 5
    Ries LAG, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1975-2001. Bethesda, MD: National Cancer Institute. Available from URL: [accessed June 2004].
  • 6
    Ciccone G, Prastaro C, Ivaldi C, et al. Access to hospital care, clinical stage and survival from colorectal cancer according to socio-economic status. Ann Oncol. 2000; 11: 12011204.
  • 7
    Jepson C, Kessler LG, Portnoy B, et al. Black-white differences in cancer prevention knowledge and behavior. Am J Public Health. 1991; 81: 501504.
  • 8
    Mandelblatt J, Andrews H, Kao R, et al. The late-stage diagnosis of colorectal cancer: demographic and socioeconomic factors. Am J Public Health. 1996; 86: 17941797.
  • 9
    Rabeneck L, El-Serag HB, Davila JA, et al. Outcomes of colorectal cancer in the United States: no change in survival (1986-1997). Am J Gastroenterol. 2003; 98: 471477.
  • 10
    Clegg LX, Li FP, Hankey BF, et al. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) program population-based study. Arch Intern Med. 2002; 162: 19851993.
  • 11
    Merrill RM, Henson DE, Ries LA. Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum. 1998; 41: 10971106.
  • 12
    Marcella S, Miller JE. Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status. J Clin Epidemiol. 2001; 54: 359366.
  • 13
    Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995; 87: 16861693.
  • 14
    Rabeneck L, Souchek J, El-Serag HB. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol. 2003; 98: 11861192.
    Direct Link:
  • 15
    Wudel LJ Jr., Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. Arch Surg. 2002; 137: 550554; discussion 554–556.
  • 16
    Govindarajan R, Shah RV, Erkman LG, et al. Racial differences in the outcome of patients with colorectal carcinoma. Cancer. 2003; 97: 493498.
  • 17
    Alexander D, Chatla C, Funkhouser E, et al. Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma. Cancer. 2004; 101: 6676.
  • 18
    Willett C. Cancer of the lower gastrointestinal tract, atlas of clinical oncology. Hamilton, Ontario: B.C. Decker Inc., 2001.
  • 19
    Harris GJ, Senagore AJ, Lavery IC, et al. Factors affecting survival after palliative resection of colorectal carcinoma. Colorectal Dis. 2002; 4: 3135.
  • 20
    Samowitz WS, Curtin K, Ma KN, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev. 2001; 10: 917923.
  • 21
    Rabeneck L, Davila JA, Thompson M, et al. Surgical volume and long-term survival following surgery for colorectal cancer in the Veterans Affairs Health-Care System. Am J Gastroenterol. 2004; 99: 668675.
    Direct Link:
  • 22
    Dominitz JA, Samsa GP, Landsman P, et al. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer. 1998; 82: 23122320.
  • 23
    Cooper GS, Yuan Z, Rimm AA. Racial disparity in the incidence and case-fatality of colorectal cancer: analysis of 329 United States counties. Cancer Epidemiol Biomarkers Prev. 1997; 6: 283285.
  • 24
    Ries LA, Kosary CL, Hankey BF, et al. SEER cancer statistics review, 1973-1994. Bethesda, MD: National Cancer Institute, NIH, 1997.
  • 25
    Weaver P, Harrison B, Eskander G, et al. Colon cancer in African-Americans: a disease with a worsening prognosis. JAMA. 1991; 83: 133136.
  • 26
    Myers MH. Survival from cancer by blacks and whites. Prog Clin Biol Res. 1981; 53: 151165.
  • 27
    Nagel S, Chung EB, DeWitty RL Jr., et al. Colorectal cancer in young black patients. JAMA. 1988; 80: 3740.
  • 28
    NCCN Aa, colon and rectal cancer treatment guidelines for patients. American Cancer Society (ACS) and the National Comprehensive Cancer Network (NCCN). Version III. Atlanta, American Cancer Society, 2003.
  • 29
    Green FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag, 2002.
  • 30
    World Health organization. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization, 1990.
  • 31
    Grizzle WE, Manne U, Jhala N, et al. The molecular characterization of colorectal neoplasia in translational research. Arch Pathol Lab Med. 2001; 125: 9198.
  • 32
    Grizzle WE, Manne U, Weiss HL, et al. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1). Int J Cancer. 2002; 97: 403409.
  • 33
    Compton C, Fenoglio-Preiser CM, Pettigrew N, et al. American Joint Committee on Cancer prognostic factors consensus conference: colorectal working group. Cancer. 2000; 88: 17391757.
  • 34
    Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000; 124: 979994.
  • 35
    Blenkinsopp WK, Stewart-Brown S, Blesovsky L, et al. Histopathology reporting in large bowel cancer. J Clin Pathol. 1981; 34: 509513.
  • 36
    Fleiss J. Statistical methods for rates and proportions. New York: John Wiley & Sons, 1981.
  • 37
    Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457481.
  • 38
    Cox DR. Regression models and life tables. J Roy Stat Soc. 1972; 34: 187220.
  • 39
    Allison P. Survival analysis using the SAS system: a practical guide. Cary, NC: SAS Institute Inc., 1995.
  • 40
    Kleinbaum D. Survival analysis: a self learning text. New York: Springer-Verlag, 1996.
  • 41
    Mostafa G, Matthews BD, Norton HJ, et al. Influence of demographics on colorectal cancer. Am Surg. 2004; 70: 259264.
  • 42
    Chen VW, Fenoglio-Preiser CM, Wu XC, et al. Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarkers Prev. 1997; 6: 10871093.
  • 43
    Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003; 349: 247257.
  • 44
    Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000; 342: 6977.
  • 45
    Rigau V, Sebbagh N, Olschwang S, et al. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining. Arch Pathol Lab Med. 2003; 127: 694700.
  • 46
    Lim SB, Jeong SY, Lee MR, et al. Prognostic significance of microsatellite instability in sporadic colorectal cancer. Int J Colorectal Dis. 2004; 19; 533537
  • 47
    Carethers JM, Smith EJ, Behling CA, et al. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology. 2004; 126: 394401.
  • 48
    Nasca P PH. Fundamentals of cancer epidemiology. 1st ed. Gaithersburg, MD: Aspen, 2001.
  • 49
    Robbins SCR, Kumar V. Pathologic basis of disease. 5th ed. Philadelphia: W.B. Saunders Company, 1994.
  • 50
    Meyerhardt JA, Catalano PJ, Haller DG, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003; 21: 433440.
  • 51
    Yancik R, Wesley MN, Ries LA, et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer. 1998; 82: 21232134.
  • 52
    Dignam JJ, Colangelo L, Tian W, et al. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst. 1999; 91: 19331940.
  • 53
    McCollum AD, Catalano PJ, Haller DG, et al. Outcomes and toxicity in African-American and Caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst. 2002; 94: 11601167.
  • 54
    Dayal H, Polissar L, Yang CY, et al. Race, socioeconomic status, and other prognostic factors for survival from colorectal cancer. J Chron Dis. 1987; 40: 857864.